MCLAUGHLIN KEVIN F
Insider CIK 1214938 · XLRN SVP, CFO and Treasurer · DBTX Director · IVVD Director · VCEL Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VCEL Vericel Corp | M Exercise deriv | 2026-08-12 | 2026-08-14 | 7,000 | — | $0 | 7,000 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2026-08-12 | 2026-08-14 | 7,000 | $44.53 | $311.7K | 18,300 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2026-08-12 | 2026-08-14 | 7,000 | $13.05 | $91.3K | 25,300 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2026-08-12 | 2026-08-14 | 7,000 | — | $0 | 7,000 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2026-08-12 | 2026-08-14 | 7,000 | $44.53 | $311.7K | 18,300 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2026-08-12 | 2026-08-14 | 7,000 | $13.05 | $91.3K | 25,300 | SEC↗ |
| IVVD Invivyd, Inc. | A Award deriv | 2026-05-19 | 2026-05-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2026-05-13 | 2026-05-15 | 3,500 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2026-05-13 | 2026-05-15 | 3,500 | — | $0 | 14,000 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2026-05-13 | 2026-05-15 | 3,500 | $32.82 | $114.9K | 18,300 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2026-05-13 | 2026-05-15 | 3,500 | $2.63 | $9.2K | 21,800 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2026-05-13 | 2026-05-15 | 3,500 | $32.83 | $114.9K | 18,300 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2026-05-13 | 2026-05-15 | 3,500 | $13.05 | $45.7K | 21,800 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2026-04-29 | 2026-05-01 | 3,200 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2026-04-29 | 2026-05-01 | 3,200 | — | $0 | 3,200 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2026-04-29 | 2026-05-01 | 8,000 | — | $0 | 8,000 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2026-04-29 | 2026-05-01 | 3,200 | — | $0 | 18,300 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2026-02-11 | 2026-02-13 | 7,000 | — | $0 | 3,500 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2026-02-11 | 2026-02-13 | 7,000 | $34.66 | $242.6K | 15,100 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2026-02-11 | 2026-02-13 | 7,000 | $2.63 | $18.4K | 22,100 | SEC↗ |
| IVVD Invivyd, Inc. | P Buy | 2025-11-19 | 2025-11-20 | 50,000 | $2.50 | $125.0K | 50,000 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2025-11-10 | 2025-11-12 | 7,000 | — | $0 | 10,500 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2025-11-10 | 2025-11-12 | 7,000 | $38.59 | $270.1K | 15,100 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2025-11-10 | 2025-11-12 | 7,000 | $2.63 | $18.4K | 22,100 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2025-08-06 | 2025-08-08 | 7,000 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2025-08-06 | 2025-08-08 | 7,000 | $35.92 | $251.4K | 15,100 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2025-08-06 | 2025-08-08 | 7,000 | $2.76 | $19.3K | 22,100 | SEC↗ |
| IVVD Invivyd, Inc. | A Award deriv | 2025-05-20 | 2025-05-22 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2025-05-07 | 2025-05-09 | 7,000 | — | $0 | 7,000 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2025-05-07 | 2025-05-09 | 7,000 | $2.76 | $19.3K | 22,100 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2025-05-07 | 2025-05-09 | 7,000 | $39.98 | $279.9K | 15,100 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2025-04-30 | 2025-05-02 | 3,200 | — | $0 | 3,200 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2025-04-30 | 2025-05-02 | 8,000 | — | $0 | 8,000 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2025-04-30 | 2025-05-02 | 3,200 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2025-04-30 | 2025-05-02 | 3,200 | — | $0 | 15,100 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2025-02-12 | 2025-02-14 | 1,000 | — | $0 | 14,000 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2025-02-12 | 2025-02-14 | 6,000 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2025-02-12 | 2025-02-14 | 6,000 | $3.74 | $22.4K | 17,900 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2025-02-12 | 2025-02-14 | 1,000 | $55.43 | $55.4K | 11,900 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2025-02-12 | 2025-02-14 | 1,000 | $2.76 | $2.8K | 12,900 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2025-02-12 | 2025-02-14 | 6,000 | $55.47 | $332.8K | 11,900 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2024-11-13 | 2024-11-15 | 7,000 | — | $0 | 6,000 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2024-11-13 | 2024-11-15 | 7,000 | $55.54 | $388.8K | 11,900 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2024-11-13 | 2024-11-15 | 7,000 | $3.74 | $26.2K | 18,900 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2024-08-07 | 2024-08-09 | 5,000 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2024-08-07 | 2024-08-09 | 2,000 | — | $0 | 13,000 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2024-08-07 | 2024-08-09 | 5,000 | $3.74 | $18.7K | 16,900 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2024-08-07 | 2024-08-09 | 5,000 | $45.92 | $229.6K | 11,900 | SEC↗ |
| VCEL Vericel Corp | S Sale | 2024-08-07 | 2024-08-09 | 2,000 | $45.99 | $92.0K | 11,900 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2024-08-07 | 2024-08-09 | 2,000 | $3.74 | $7.5K | 13,900 | SEC↗ |
| IVVD Invivyd, Inc. | A Award deriv | 2024-05-21 | 2024-05-23 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2024-05-01 | 2024-05-03 | 3,200 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2024-05-01 | 2024-05-03 | 8,000 | — | $0 | 8,000 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2024-05-01 | 2024-05-03 | 3,200 | — | $0 | 3,200 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2024-05-01 | 2024-05-03 | 3,200 | — | $0 | 11,900 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | D To issuer deriv | 2023-09-25 | 2023-09-25 | 20,000 | — | $0 | 0 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | D To issuer deriv | 2023-09-25 | 2023-09-25 | 5,000 | — | $0 | 0 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | D To issuer | 2023-09-25 | 2023-09-25 | 5,000 | — | $0 | 0 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | A Award deriv | 2023-06-13 | 2023-06-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | A Award | 2023-06-13 | 2023-06-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2023-05-03 | 2023-05-05 | 3,200 | — | $0 | 3,200 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2023-05-03 | 2023-05-05 | 8,000 | — | $0 | 8,000 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2023-04-27 | 2023-04-28 | 2,600 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2023-04-27 | 2023-04-28 | 2,600 | — | $0 | 8,700 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | A Award deriv | 2022-10-10 | 2022-10-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2022-04-27 | 2022-04-29 | 2,600 | — | $0 | 2,600 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2022-04-27 | 2022-04-29 | 2,600 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2022-04-27 | 2022-04-29 | 6,500 | — | $0 | 6,500 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2022-04-27 | 2022-04-29 | 2,600 | — | $0 | 6,100 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 20,500 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 18,806 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 24,334 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 11,262 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | D To issuer deriv | 2021-11-19 | 2021-11-22 | 2,663 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | U Tender | 2021-11-19 | 2021-11-22 | 10,681 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2021-09-24 | 2021-09-24 | 5,200 | — | $0 | 11,262 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2021-09-24 | 2021-09-24 | 170 | — | $0 | 20,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2021-09-24 | 2021-09-24 | 170 | $41.64 | $7.1K | 16,051 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-09-24 | 2021-09-24 | 5,370 | $160.38 | $861.2K | 10,681 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2021-09-24 | 2021-09-24 | 5,200 | $40.61 | $211.2K | 15,881 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2021-09-23 | 2021-09-24 | 2,500 | — | $0 | 2,663 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2021-09-23 | 2021-09-24 | 7,330 | — | $0 | 20,670 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2021-09-23 | 2021-09-24 | 9,800 | — | $0 | 16,462 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-09-23 | 2021-09-24 | 18,647 | $160.26 | $2.99M | 11,664 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2021-09-23 | 2021-09-24 | 7,330 | $41.64 | $305.2K | 30,311 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-09-23 | 2021-09-24 | 983 | $161.26 | $158.5K | 10,681 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2021-09-23 | 2021-09-24 | 9,800 | $40.61 | $398.0K | 22,981 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2021-09-23 | 2021-09-24 | 2,500 | $30.17 | $75.4K | 13,181 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2021-04-28 | 2021-04-30 | 2,600 | — | $0 | 2,600 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2021-04-28 | 2021-04-30 | 6,500 | — | $0 | 6,500 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2021-04-28 | 2021-04-30 | 1,750 | — | $0 | 0 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2021-04-28 | 2021-04-30 | 1,750 | — | $0 | 3,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2021-01-29 | 2021-02-02 | 18,806 | — | $0 | 18,806 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2021-01-29 | 2021-02-02 | 4,868 | — | $0 | 10,681 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-01-05 | 2021-01-06 | 700 | $120.43 | $84.3K | 6,612 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-01-05 | 2021-01-06 | 499 | $121.89 | $60.8K | 6,113 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-01-05 | 2021-01-06 | 296 | $122.85 | $36.4K | 5,817 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-01-05 | 2021-01-06 | 4 | $123.50 | $494 | 5,813 | SEC↗ |
| XLRN ACCELERON PHARMA INC | F Tax w/h | 2021-01-04 | 2021-01-06 | 624 | $124.31 | $77.6K | 10,592 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-01-04 | 2021-01-06 | 300 | $124.45 | $37.3K | 7,312 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-01-04 | 2021-01-06 | 800 | $123.54 | $98.8K | 9,792 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-01-04 | 2021-01-06 | 713 | $124.28 | $88.6K | 9,079 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-01-04 | 2021-01-06 | 200 | $125.49 | $25.1K | 8,879 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-01-04 | 2021-01-06 | 600 | $123.49 | $74.1K | 8,279 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2021-01-04 | 2021-01-06 | 667 | $124.47 | $83.0K | 7,612 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2020-12-14 | 2020-12-15 | 7,700 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2020-12-14 | 2020-12-15 | 7,252 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2020-12-14 | 2020-12-15 | 24,986 | — | $0 | 5,163 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2020-12-14 | 2020-12-15 | 2,590 | — | $0 | 26,262 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2020-12-14 | 2020-12-15 | 24,986 | $30.17 | $753.8K | 51,154 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2020-12-14 | 2020-12-15 | 7,700 | $27.97 | $215.4K | 26,168 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-12-14 | 2020-12-15 | 42,528 | $130.14 | $5.53M | 11,216 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2020-12-14 | 2020-12-15 | 2,590 | $40.61 | $105.2K | 53,744 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2020-12-14 | 2020-12-15 | 7,252 | $41.20 | $298.8K | 18,468 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2020-12-11 | 2020-12-11 | 3,100 | — | $0 | 7,252 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2020-12-11 | 2020-12-11 | 3,100 | $41.20 | $127.7K | 14,316 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-12-11 | 2020-12-11 | 3,100 | $125.00 | $387.5K | 11,216 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2020-12-10 | 2020-12-11 | 100 | — | $0 | 28,852 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2020-12-10 | 2020-12-11 | 100 | — | $0 | 10,352 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2020-12-10 | 2020-12-11 | 200 | — | $0 | 7,700 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2020-12-10 | 2020-12-11 | 100 | — | $0 | 30,149 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2020-12-10 | 2020-12-11 | 100 | $30.17 | $3.0K | 11,616 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2020-12-10 | 2020-12-11 | 100 | $40.61 | $4.1K | 11,716 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-12-10 | 2020-12-11 | 500 | $125.12 | $62.6K | 11,216 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2020-12-10 | 2020-12-11 | 200 | $27.97 | $5.6K | 11,516 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2020-12-10 | 2020-12-11 | 100 | $41.20 | $4.1K | 11,316 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2020-12-09 | 2020-12-11 | 1,873 | — | $0 | 28,952 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2020-12-09 | 2020-12-11 | 1,051 | — | $0 | 30,249 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2020-12-09 | 2020-12-11 | 400 | — | $0 | 7,900 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2020-12-09 | 2020-12-11 | 548 | — | $0 | 10,452 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2020-12-09 | 2020-12-11 | 548 | $41.20 | $22.6K | 11,764 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2020-12-09 | 2020-12-11 | 400 | $27.97 | $11.2K | 12,164 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2020-12-09 | 2020-12-11 | 1,051 | $30.17 | $31.7K | 13,215 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2020-12-09 | 2020-12-11 | 1,873 | $40.61 | $76.1K | 15,088 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-12-09 | 2020-12-11 | 3,872 | $125.03 | $484.1K | 11,216 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2020-04-29 | 2020-05-01 | 1,750 | — | $0 | 1,750 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2020-04-29 | 2020-05-01 | 13,125 | — | $0 | 13,125 | SEC↗ |
| VCEL Vericel Corp | M Exercise deriv | 2020-04-29 | 2020-05-01 | 1,750 | $14.56 | $25.5K | 0 | SEC↗ |
| VCEL Vericel Corp | M Exercise | 2020-04-29 | 2020-05-01 | 1,750 | — | $0 | 1,750 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2020-04-09 | 2020-04-10 | 17,226 | — | $0 | 11,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2020-04-09 | 2020-04-10 | 17,226 | $41.20 | $709.7K | 28,442 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-04-09 | 2020-04-10 | 17,226 | $88.19 | $1.52M | 11,216 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2020-04-08 | 2020-04-10 | 4,000 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2020-04-08 | 2020-04-10 | 10,000 | — | $0 | 31,300 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2020-04-08 | 2020-04-10 | 12,774 | — | $0 | 28,226 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2020-04-08 | 2020-04-10 | 10,000 | — | $0 | 8,300 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-04-08 | 2020-04-10 | 2,900 | $82.83 | $240.2K | 45,090 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2020-04-08 | 2020-04-10 | 10,000 | $30.17 | $301.7K | 47,990 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2020-04-08 | 2020-04-10 | 10,000 | $27.97 | $279.7K | 37,990 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2020-04-08 | 2020-04-10 | 12,774 | $41.20 | $526.3K | 27,990 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2020-04-08 | 2020-04-10 | 4,000 | $24.11 | $96.4K | 15,216 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-04-08 | 2020-04-10 | 3,803 | $84.89 | $322.8K | 36,250 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-04-08 | 2020-04-10 | 5,921 | $86.79 | $513.9K | 14,919 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-04-08 | 2020-04-10 | 3,703 | $87.50 | $324.0K | 11,216 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-04-08 | 2020-04-10 | 5,037 | $83.68 | $421.5K | 40,053 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-04-08 | 2020-04-10 | 15,410 | $85.80 | $1.32M | 20,840 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2020-01-22 | 2020-01-24 | 24,334 | — | $0 | 24,334 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2020-01-22 | 2020-01-24 | 6,369 | — | $0 | 11,216 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-01-02 | 2020-01-03 | 1,566 | $52.52 | $82.2K | 4,847 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-01-02 | 2020-01-03 | 2,300 | $52.49 | $120.7K | 6,413 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2020-01-02 | 2020-01-03 | 1,713 | $52.51 | $89.9K | 8,713 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-12-13 | 2019-12-17 | 11,853 | $50.28 | $596.0K | 10,426 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-09-10 | 2019-09-10 | 7,827 | $45.29 | $354.5K | 22,452 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-09-10 | 2019-09-10 | 173 | $45.75 | $7.9K | 22,279 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2019-05-01 | 2019-05-03 | 13,125 | — | $0 | 13,125 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2019-05-01 | 2019-05-03 | 1,750 | — | $0 | 1,750 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-04-09 | 2019-04-11 | 100 | $45.46 | $4.5K | 30,279 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-04-09 | 2019-04-11 | 11,900 | $44.61 | $530.9K | 30,379 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-04-02 | 2019-04-04 | 648 | $48.02 | $31.1K | 42,279 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2019-01-25 | 2019-01-29 | 28,000 | — | $0 | 28,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2019-01-25 | 2019-01-29 | 4,700 | — | $0 | 42,927 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-01-02 | 2019-01-04 | 1,717 | $43.33 | $74.4K | 38,324 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-01-02 | 2019-01-04 | 2,186 | $42.56 | $93.0K | 40,041 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-01-02 | 2019-01-04 | 97 | $44.06 | $4.3K | 38,227 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-01-02 | 2019-01-04 | 1,412 | $42.37 | $59.8K | 42,527 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-01-02 | 2019-01-04 | 300 | $43.20 | $13.0K | 42,227 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2018-08-30 | 2018-08-31 | 12,500 | — | $0 | 18,300 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2018-08-30 | 2018-08-31 | 12,500 | $54.00 | $675.0K | 43,939 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2018-08-30 | 2018-08-31 | 12,500 | $27.97 | $349.6K | 56,439 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2018-06-29 | 2018-07-03 | 25,000 | — | $0 | 4,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2018-06-29 | 2018-07-03 | 12,500 | $49.00 | $612.5K | 43,939 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2018-06-29 | 2018-07-03 | 12,500 | $47.00 | $587.5K | 56,439 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2018-06-29 | 2018-07-03 | 25,000 | $24.11 | $602.8K | 68,939 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2018-05-02 | 2018-05-03 | 17,500 | — | $0 | 17,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2018-04-03 | 2018-04-04 | 800 | $39.00 | $31.2K | 43,939 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2018-04-03 | 2018-04-04 | 3,200 | $38.31 | $122.6K | 44,739 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2018-03-01 | 2018-03-05 | 30,825 | — | $0 | 30,825 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2018-03-01 | 2018-03-05 | 5,138 | — | $0 | 47,939 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2018-01-04 | 2018-01-04 | 14,800 | $43.00 | $636.4K | 43,001 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2018-01-04 | 2018-01-04 | 200 | $43.84 | $8.8K | 42,801 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2018-01-03 | 2018-01-04 | 6,251 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2018-01-03 | 2018-01-04 | 6,250 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2018-01-03 | 2018-01-04 | 6,251 | $3.88 | $24.3K | 51,551 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2018-01-03 | 2018-01-04 | 6,250 | $5.28 | $33.0K | 57,801 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2018-01-02 | 2018-01-04 | 4,000 | $42.42 | $169.7K | 45,300 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2017-09-12 | 2017-09-14 | 210 | $39.85 | $8.4K | 49,300 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2017-09-12 | 2017-09-14 | 1,300 | $39.17 | $50.9K | 49,510 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2017-09-12 | 2017-09-14 | 14,490 | $38.32 | $555.3K | 50,810 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2017-07-05 | 2017-07-07 | 18,750 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2017-07-05 | 2017-07-07 | 3,150 | — | $0 | 6,250 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2017-07-05 | 2017-07-07 | 34,400 | $32.00 | $1.10M | 65,300 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2017-07-05 | 2017-07-07 | 18,750 | $7.12 | $133.5K | 99,700 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2017-07-05 | 2017-07-07 | 3,150 | $5.28 | $16.6K | 80,950 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2017-05-03 | 2017-05-05 | 17,500 | — | $0 | 17,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2017-03-02 | 2017-03-14 | 41,300 | — | $0 | 41,300 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2017-03-02 | 2017-03-14 | 6,900 | — | $0 | 77,800 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2017-01-04 | 2017-01-06 | 400 | $26.87 | $10.7K | 72,200 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2017-01-04 | 2017-01-06 | 1,300 | $27.63 | $35.9K | 70,900 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2017-01-03 | 2017-01-04 | 10,000 | — | $0 | 6,251 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2017-01-03 | 2017-01-04 | 10,000 | $3.88 | $38.8K | 72,600 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-07-07 | 2016-07-07 | 5,000 | — | $0 | 16,251 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-07-07 | 2016-07-07 | 5,000 | $3.88 | $19.4K | 62,600 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-07-01 | 2016-07-06 | 15,300 | — | $0 | 9,400 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2016-07-01 | 2016-07-06 | 25,300 | $34.66 | $876.9K | 57,600 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-07-01 | 2016-07-06 | 15,300 | $5.28 | $80.8K | 82,900 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-05-23 | 2016-05-25 | 300 | — | $0 | 24,700 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2016-05-23 | 2016-05-25 | 25,300 | $34.00 | $860.2K | 67,600 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-05-23 | 2016-05-25 | 300 | $5.28 | $1.6K | 92,900 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2016-05-04 | 2016-05-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2016-03-03 | 2016-03-07 | 30,800 | — | $0 | 30,800 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2016-03-03 | 2016-03-07 | 5,100 | — | $0 | 92,600 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-12-22 | 2015-12-23 | 7,500 | — | $0 | 21,251 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-12-22 | 2015-12-23 | 7,500 | $3.88 | $29.1K | 87,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-10-07 | 2015-10-09 | 7,000 | — | $0 | 28,751 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-10-07 | 2015-10-09 | 3,460 | $24.64 | $85.3K | 80,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-10-07 | 2015-10-09 | 3,540 | $24.12 | $85.4K | 83,460 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-10-07 | 2015-10-09 | 7,000 | $3.88 | $27.2K | 87,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2015-09-09 | 2015-09-11 | 40,000 | — | $0 | 80,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-09-08 | 2015-09-10 | 1,500 | — | $0 | 35,751 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-09-08 | 2015-09-10 | 5,000 | — | $0 | 37,251 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-09-08 | 2015-09-10 | 1,293 | $31.07 | $40.2K | 40,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-09-08 | 2015-09-10 | 5,000 | $3.88 | $19.4K | 45,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-09-08 | 2015-09-10 | 724 | $30.45 | $22.0K | 40,176 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-09-08 | 2015-09-10 | 600 | $29.39 | $17.6K | 40,900 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-09-08 | 2015-09-10 | 1,500 | $3.88 | $5.8K | 41,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-09-08 | 2015-09-10 | 176 | $31.16 | $5.5K | 40,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-09-08 | 2015-09-10 | 2,500 | $30.22 | $75.5K | 41,293 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-09-08 | 2015-09-10 | 1,207 | $29.11 | $35.1K | 43,793 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-08-10 | 2015-08-12 | 1,500 | — | $0 | 42,251 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-08-10 | 2015-08-12 | 5,000 | — | $0 | 43,751 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-08-10 | 2015-08-12 | 1,500 | $28.54 | $42.8K | 40,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-08-10 | 2015-08-12 | 5,000 | $3.88 | $19.4K | 45,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-08-10 | 2015-08-12 | 4,900 | $28.51 | $139.7K | 40,100 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-08-10 | 2015-08-12 | 100 | $29.23 | $2.9K | 40,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-08-10 | 2015-08-12 | 1,500 | $3.88 | $5.8K | 41,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-07-28 | 2015-07-30 | 5,000 | — | $0 | 48,751 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-07-28 | 2015-07-30 | 5,000 | $3.88 | $19.4K | 40,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-07-07 | 2015-07-09 | 5,000 | — | $0 | 55,751 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-07-07 | 2015-07-09 | 2,000 | — | $0 | 53,751 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-07-07 | 2015-07-09 | 4,623 | $29.65 | $137.1K | 35,377 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-07-07 | 2015-07-09 | 95 | $30.39 | $2.9K | 35,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-07-07 | 2015-07-09 | 1,905 | $29.68 | $56.5K | 35,095 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-07-07 | 2015-07-09 | 2,000 | $3.88 | $7.8K | 37,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-07-07 | 2015-07-09 | 5,000 | $3.88 | $19.4K | 40,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-07-07 | 2015-07-09 | 377 | $30.27 | $11.4K | 35,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-06-10 | 2015-06-10 | 5,000 | — | $0 | 60,751 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-06-10 | 2015-06-10 | 5,000 | $3.88 | $19.4K | 35,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-06-08 | 2015-06-09 | 1,500 | — | $0 | 65,751 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-06-08 | 2015-06-09 | 5,000 | — | $0 | 67,251 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-06-08 | 2015-06-09 | 100 | $32.97 | $3.3K | 30,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-06-08 | 2015-06-09 | 1,500 | $3.88 | $5.8K | 31,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-06-08 | 2015-06-09 | 1,300 | $32.37 | $42.1K | 30,200 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-06-08 | 2015-06-09 | 5,000 | $3.88 | $19.4K | 35,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-06-08 | 2015-06-09 | 200 | $32.96 | $6.6K | 30,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-06-08 | 2015-06-09 | 4,900 | $32.49 | $159.2K | 30,100 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-05-11 | 2015-05-13 | 5,000 | — | $0 | 72,251 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-05-11 | 2015-05-13 | 6,500 | — | $0 | 77,251 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-05-11 | 2015-05-13 | 1,500 | $31.78 | $47.7K | 25,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-05-11 | 2015-05-13 | 6,500 | $3.88 | $25.2K | 31,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-05-11 | 2015-05-13 | 4,900 | $31.79 | $155.8K | 26,600 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-05-11 | 2015-05-13 | 100 | $32.40 | $3.2K | 26,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-05-11 | 2015-05-13 | 5,000 | $3.88 | $19.4K | 30,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-04-07 | 2015-04-08 | 5,000 | — | $0 | 83,751 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-04-07 | 2015-04-08 | 2,000 | — | $0 | 88,751 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-04-07 | 2015-04-08 | 5,000 | $3.88 | $19.4K | 30,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-04-07 | 2015-04-08 | 250 | $35.52 | $8.9K | 25,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-04-07 | 2015-04-08 | 1,750 | $34.82 | $60.9K | 25,250 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-04-07 | 2015-04-08 | 2,000 | $3.88 | $7.8K | 27,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-04-07 | 2015-04-08 | 500 | $35.50 | $17.8K | 25,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-04-07 | 2015-04-08 | 4,500 | $34.80 | $156.6K | 25,500 | SEC↗ |
| VCEL Vericel Corp | A Award deriv | 2015-03-20 | 2015-03-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-03-09 | 2015-03-10 | 5,000 | — | $0 | 92,251 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-03-09 | 2015-03-10 | 1,500 | — | $0 | 90,751 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-09 | 2015-03-10 | 200 | $40.94 | $8.2K | 25,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-03-09 | 2015-03-10 | 5,000 | $3.88 | $19.4K | 30,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-09 | 2015-03-10 | 4,381 | $40.16 | $175.9K | 25,619 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-09 | 2015-03-10 | 619 | $40.93 | $25.3K | 25,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-03-09 | 2015-03-10 | 1,500 | $3.88 | $5.8K | 26,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-09 | 2015-03-10 | 1,300 | $40.14 | $52.2K | 25,200 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-02-09 | 2015-02-11 | 1,500 | — | $0 | 97,251 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-02-09 | 2015-02-11 | 5,000 | — | $0 | 98,751 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-02-09 | 2015-02-11 | 5,000 | $3.88 | $19.4K | 30,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-02-09 | 2015-02-11 | 1,500 | $3.88 | $5.8K | 26,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-02-09 | 2015-02-11 | 1,500 | $36.65 | $55.0K | 25,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-02-09 | 2015-02-11 | 4,600 | $36.60 | $168.4K | 25,400 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-02-09 | 2015-02-11 | 400 | $37.11 | $14.8K | 25,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-01-12 | 2015-01-13 | 2,000 | — | $0 | 103,751 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-01-12 | 2015-01-13 | 845 | $41.04 | $34.7K | 25,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-01-12 | 2015-01-13 | 2,000 | $3.88 | $7.8K | 27,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-01-12 | 2015-01-13 | 1,155 | $40.38 | $46.6K | 25,845 | SEC↗ |